This inventor holds 1 USPTO granted patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Osamu Kaneko: Innovator in Cancer Treatment
Introduction: Osamu Kaneko is a notable inventor based in Stanford, CA, who has made significant contributions to the field of cancer research. His innovative work focuses on disrupting the binding interaction between mesothelin and CA125, which is crucial for the growth and progression of certain cancers.
Latest Patents: Kaneko holds a patent for "Blocking mesothelin peptide fragments." This invention provides mesothelin peptide fragments that correspond to the CA125 binding site of mesothelin. The peptide fragments are designed to disrupt the binding interaction between mesothelin and CA125, offering potential therapeutic applications in the treatment and prevention of cancers that rely on this interaction for their growth and metastasis. He has 1 patent to his name.
Career Highlights: Kaneko's career is marked by his dedication to advancing cancer treatment methodologies. His work has been recognized for its potential impact on improving patient outcomes in oncology.
Collaborations: He has collaborated with esteemed colleagues, including Mitchell Ho and Byungkook Lee, to further enhance the research and development of cancer therapies.
Conclusion: Osamu Kaneko's innovative contributions to cancer research exemplify the importance of scientific advancements in the fight against cancer. His work continues to inspire future research in this critical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile